Nucleic acid vaccine candidates encapsulated with mesoporous silica nanoparticles against MERS-CoV
ABSTRACTMiddle East respiratory coronavirus (MERS-CoV) is a newly emergent, highly pathogenic coronavirus that is associated with 34% mortality rate. MERS-CoV remains listed as priority pathogen by the WHO. Since its discovery in 2012 and despite the efforts to develop coronaviruses vaccines to figh...
Saved in:
Main Authors: | Iman Almansour (Author), B. Rabindran Jermy (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mesoporous Silica Nanoparticles for Co-Delivery of Drugs and Nucleic Acids in Oncology: A Review
by: Juan L. Paris, et al.
Published: (2020) -
Strategies to Obtain Encapsulation and Controlled Release of Pentamidine in Mesoporous Silica Nanoparticles
by: Enrico Peretti, et al.
Published: (2018) -
Increasing Bioavailability of Trans-Ferulic Acid by Encapsulation in Functionalized Mesoporous Silica
by: Gabriela Petrișor, et al.
Published: (2023) -
Resveratrol Encapsulation and Release from Pristine and Functionalized Mesoporous Silica Carriers
by: Simona Ioniţă, et al.
Published: (2022) -
Mesoporous silica nanoparticles for drug and gene delivery
by: Yixian Zhou, et al.
Published: (2018)